HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Closes Another Business Smuggling Drugs From China As Dietary Ingredients

This article was originally published in The Rose Sheet

Executive Summary

Importer Pure Assay Ingredients, owners Lynn Chau and Bao Luu charged in seven-count indictment with conspiring to deceive US Customs with stimulants labeled as melatonin, sucralose or other dietary ingredients. Also charged are two Chinese citizens who worked for Pure Assay in Chengdu, China, to bring the illegal substances to the US.

You may also be interested in...



Sales Of Drug-Spiked Rhino Supplements Trouble FDA After Importer's Arrest

FDA's consumer warning about "Rhino" brand male enhancement products "due to a recent rise in reported health issues" marks latest detected use of ED ingredients in products fraudulently labeled as supplements and latest example of businesses flouting s regulatory framework that allows sales of most supplements without any pre-market approval process. FDA also uses announcement to recommend consumers ask for a health care provider's advice before "using or considering using any product marketed as a dietary supplement."

Ion Spectrometer Improves FDA's Import Screening: Health And Wellness Industry News

FDA implementing ion mobility spectrometer devices for faster import screening; Kratom products recalled in Utah in salmonella investigation; ABC names Low Dog first Kronenberg Award winner; and AHPA revises liability insurance primer.

DMAA, Other Stimulants Cast Shadow Over FDA Supplement Regulation – Study

Six workout and weight loss brands contained DMAA and three other stimulants, according to a study in the Journal Clinical Toxicology. Researchers concluded consumers must be informed of risk so they know to check labels for three substances that indicate the presence of the stimulants.

Related Content

Topics

UsernamePublicRestriction

Register

RS122554

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel